U.S. Supreme Court
Apr. 17, 2012
High court to weigh whether pharmaceutical sales rep can get overtime
In a case with implications for the flood of wage and hour lawsuits targeting drugmakers, the U.S. Supreme Court will consider next week whether pharmaceutical sales representatives should be paid for overtime.
Daily Journal Staff Writer
WASHINGTON - In a case with implications for a flood of wage-and-hour lawsuits targeting drugmakers, the U.S. Supreme Court will consider today whether pharmaceutical sales representatives should be paid for overtime.
The court will review a 9th U.S. Circuit Court of Appeals decision holding that GlaxoSmithKline PLC is not required to pay its reps for extra hours worked because, as outside salespers...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In